Pharmaceuticals News

This Midcap Pharma Stock Trading 7% Up From 52 Week Low, Buy For Robust 40% Gains: Motilal Oswal

This Midcap Pharma Stock Trading 7% Up From 52 Week Low, Buy For Robust 40% Gains: Motilal Oswal

Multibagger Pharma Stock Tanks 9% In 2 Days, Hits New 52-Week Low, Buy For 51% Gains: ICICI Direct

Multibagger Pharma Stock Tanks 9% In 2 Days, Hits New 52-Week Low, Buy For 51% Gains: ICICI Direct

Buy This Pharma Stock, Trading 2% Away From 52-Week Low, For 57% Gain: Motilal Oswal

Buy This Pharma Stock, Trading 2% Away From 52-Week Low, For 57% Gain: Motilal Oswal

Record Date For Dividend: Multibagger Small Cap Pharma Stock Decides Date, 3-Months Return 71%

Record Date For Dividend: Multibagger Small Cap Pharma Stock Decides Date, 3-Months Return 71%

This Small Cap Pharma Stock Jumps 20%, Hits Upper Circuit Today

This Small Cap Pharma Stock Jumps 20%, Hits Upper Circuit Today

ICICI Direct Bets On This Large Cap Pharma Stock, Suggests Buy For 17% Potential Gains

ICICI Direct Bets On This Large Cap Pharma Stock, Suggests Buy For 17% Potential Gains

Buy This 5th Largest Branded Pharma Stock For Target Price Of Rs 445: KR Choksey

Buy This 5th Largest Branded Pharma Stock For Target Price Of Rs 445: KR Choksey

Buy This Mid-Cap Pharma Stock For Target Price Of Rs 645, Q1FY23 Revenue Rose 9.4% YoY: Geojit

Buy This Mid-Cap Pharma Stock For Target Price Of Rs 645, Q1FY23 Revenue Rose 9.4% YoY: Geojit

This Recently Listed Small Cap Pharma Stock Likely To Surge 15%, Brokerage Rates Accumulate

This Recently Listed Small Cap Pharma Stock Likely To Surge 15%, Brokerage Rates Accumulate

Intercept Pharmaceuticals Settles Ocaliva Patent Litigation Case, With Dr Reddy's

Intercept Pharmaceuticals Settles Ocaliva Patent Litigation Case, With Dr Reddy's

Stock To Buy: This Multibagger Small Cap Pharma Stock Gets 'Buy' Rating For 17% Gains

Stock To Buy: This Multibagger Small Cap Pharma Stock Gets 'Buy' Rating For 17% Gains

Sharekhan Bets On This Large Cap Pharma Stock For 19% Potential Upside, Given 130% Returns In 5 Year

Sharekhan Bets On This Large Cap Pharma Stock For 19% Potential Upside, Given 130% Returns In 5 Year

This Multibagger Pharma Stock Fixes Record Date In August For 1500% Dividend, Details Inside

This Multibagger Pharma Stock Fixes Record Date In August For 1500% Dividend, Details Inside

Glenmark Pharmaceuticals Acquires Certain OTC Drugs ,From Wockhardt In US

Glenmark Pharmaceuticals Acquires Certain OTC Drugs ,From Wockhardt In US

Buy This Pharma Stock For 20% Returns, Reported Robust Revenue Of Rs 1,030 Crore: Geojit

Buy This Pharma Stock For 20% Returns, Reported Robust Revenue Of Rs 1,030 Crore: Geojit

Motilal Oswal Suggests Buy This Pharma Stock, Revenue Rose To Rs 52.2b, Announced 600% Dividend

Motilal Oswal Suggests Buy This Pharma Stock, Revenue Rose To Rs 52.2b, Announced 600% Dividend

Buy This Pharmaceutical Stock For A Target Price Of Rs 1,150: Sharekhan

Buy This Pharmaceutical Stock For A Target Price Of Rs 1,150: Sharekhan

Macleods pharma IPO: Mumbai-based Pharma Company Has Filed DRHP With SEBI

Macleods pharma IPO: Mumbai-based Pharma Company Has Filed DRHP With SEBI

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+